Effective March 1, 2022, healthcare providers will have to obtain prior approval to administer three specific injections. The following medications are used in cancer treatment and now require prior authorization:
Name of the drug | Procedure code |
Belrapzo | J9036 |
Sarclisa | J9227 |
Khapzory | J0642 |
Unauthorized services performed on or after March 1, 2022, will be denied. You can obtain prior approval on the
Availity provider portal.
Source: